Effects of ZSET1446/ST101 on cognitive deficits and amyloid β deposition in the senescence accelerated prone mouse brain

Journal of Pharmacological Sciences

Volumn 119, Issue 2, 2012, Pages 160-166

  Yamaguchi, Yoshimasa ^a   Saito, Kenichi ^a   Matsuno, Toshiyuki ^a   Takeda, Kentaro ^a   Hino, Masataka ^a  

^a ZENYAKU KOGYO CO LTD   (Japan)

Author keywords

Amyloid ; Grading score; Object recognition test; Senescence accelerated prone mouse strain 8 (SAMP8); ZSET1446

Indexed keywords

AMYLOID BETA PROTEIN; IMIDAZO[1,2 A]PYRIDINE DERIVATIVE; SPIRO[IMIDAZO [1,2 A]PYRIDINE 3,2 INDAN] 2 (3H) ONE; ST 101; UNCLASSIFIED DRUG; ZSET 1446;

AGING; ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG SYNTHESIS; EXPLORATORY BEHAVIOR; FLUID INTAKE; HIPPOCAMPUS; IMMUNOREACTIVITY; LOCOMOTION; MALE; MOUSE; NONHUMAN; OBJECT RECOGNITION TEST; PROTEIN CLEAVAGE; RECOGNITION; SCORING SYSTEM; SENESCENCE; SENESCENCE ACCELERATED MOUSE; TASK PERFORMANCE;

EID: 84863104287     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12036FP     Document Type: Article

References (34)

1. Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron. 2004;44: 181-193. (Pubitemid 39348839)
2. Nomura Y. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: preface: pharmacological/underlying interventions for Alzheimer's disease. J Pharmacol Sci. 2012;118:317-318.
3. Takeda T, Hosokawa M, Takeshita S, Irino M, Higuchi K, Matsushita T, et al. A new model of accelerated senescence. Mech Ageing Dev. 1981;17:183-194.
4. Kumar VB, Vyas K, Franko M, Choudhary V, Buddhiraju C, Alvarez J, et al. Molecular cloning, expression, and regulation of hippocampal amyloid precursor protein of senescence accelerated mouse (SAMP8). Biochem Cell Biol. 2001;79:57-67. (Pubitemid 32150976)
5. Kumar VB, Franko M, Banks WA, Kasinahuni P, Farr SA, Vyas K, et al. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing. J Exp Biol. 2009;212:494-498.
6. Miyamoto M, Kiyota Y, Yamazaki N, Nagaoka A, Matsuno T, Nagawa Y, et al. Age-related changes in learning and memory in the senescence-accelerated mouse (SAM). Physiol Behav. 1986; 38:399-409.
7. Flood JF, Morley JE, LaReginna M. Age-related changes in the pharmacological improvement of retention in senescence accelerated mouse (SAM). Neurobiol Aging. 1993;14:159-166. (Pubitemid 23103768)
8. Okuma Y, Nomura Y. Senescence-accelerated mouse (SAM) as an animal model of senile dementia: pharmacological, neurochemical and molecular biological approach. Jpn J Pharmacol. 1998;78:399-404. (Pubitemid 29052060)
9. Takemura M, Nakamura S, Akiguchi I, Ueno M, Oka N, Ishikawa S, et al. β/A4 protein-like immunoreactive granular structures in the brain of senescence-accelerated mouse. Am J Pathol. 1993; 142:1887-1897. (Pubitemid 24057083)
10. Fukunari A, Kato A, Sakai Y, Yoshimoto T, Ishimura S, Suzuki K, et al. Colocalization of prolyl endopeptidase and amyloid β-peptide in brains of senescence-accelerated mouse. Neurosci Lett. 1994;176:201-204.
11. Del Valle J, Duran-Vilaregut J, Manich G, Casadesús G, Smith MA, Camins A, et al. Early amyloid accumulation in the hippocampus of SAMP8 mice. J Alzheimers Dis. 2010;19:1303-1315.
12. Canudas AM, Gutierrez-Cuesta J, Rodriguez MI, Acuna- Castroviejo D, Sureda FX, Camins A, et al. Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM). Mech Ageing Dev. 2005;126:1300-1304. (Pubitemid 41572247)
13. Butterfield DA, Poon HF. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Exp Gerontol. 2005;40:774-783. (Pubitemid 41416540)
14. Pallas M, Camins A, Smith MA, Perry G, Lee HG, Casadesus G. From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). J Alz heimers Dis. 2008;15:615-624.
15. Yamaguchi Y, Takano M, Saito K, Matsuno T, Kawashima S. Enhancement of acetylcholine release by ZSET845 and ZSET1446 in the rat hippocampus. Neurosci Res. 2002; 26 Suppl:S131.
16. Yamaguchi Y, Takano M, Saito K, Matsuno T, Kawashima S. Effects of ZSET845 and ZSET1446 on acetylcholine release in the cortex and learning impairments in the rat. In: Hanin I, Fisher A, Cacabelos R, editors. New trends in Alzheimer and Parkinson related disorders. Bologna: Monduzzi Editore; 2003. p. 145-148.
17. Yamaguchi Y, Miyashita H, Tsunekawa H, Mouri A, Kim H-C, Saito K, et al. Effects of a novel cognitive enhancer, spiro[imidazo- [1,2-a]pyridine-3,2-indan] -2(3H)-one, on learning impairments induced by amyloid-β1-40 in the rat. J Pharmacol Exp Ther. 2006;317:1079-1087. (Pubitemid 43764111)
18. Ito Y, Takuma K, Mizoguchi H, Nagai T, Yamada K. A novel azaindolizinone derivative ZSET1446 (spiro[imidazo[1,2-a] pyridine-3,2-indan]-2(3H)-one) improves methamphetamine-induced impairment of recognition memory in mice by activating extracellular signal-regulated kinase 1/2. J Pharmacol Exp Ther. 2007;320:819-827. (Pubitemid 46147964)
19. 2+/calmodulin kinas II and protein kinase C in mouse hippocampus. J Pharmacol Exp Ther. 2008;326:127-134.
20. Green KN, Khashwji H, Estrada T, LaFerla FM. ST101 induces a novel 17kDa APP cleavage that precludes Aβ generation in vivo. Ann Neurol. 2011;69:831-844.
21. Ennaceur A, Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brainv Res. 1988;31:47-59.
22. 3H]nitrendipine to cerebral cortical and hippocampal membranes of senescence accelerated mouse. Neurosci Lett. 1989;106:334-338.
23. Nomura Y, Kitamura Y, Ohnuki T, Arima T, Yamanaka Y, Sasaki K, et al. Alterations in acetylcholine, NMDA, benzodiazepine receptors and protein kinase C in the brain of the senescence-accelerated mouse: an animal model useful for studies on cognitive enhancers. Behav Brain Res. 1997;83:51-55. (Pubitemid 27086614)
24. Strong R, Reddy V, Morley JE. Cholinergic deficits in the septalhippocampal pathway of the SAM-P/8 senescence accelerated mouse. Brain Res. 2003;966:150-156. (Pubitemid 36315850)
25. Wang F, Chen H, Sun X. Age-related spatial cognitive impairment is correlated with decrease in ChAT in the cerebral cortex, hippocampus and forebrain of SAMP8 mice. Neurosci Lett. 2009;454:212-217.
26. 3H]acetylcholine release from brain slices of senescence-accelerated mouse. Int J Dev Neurosci. 1992;10: 121-129.
27. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 1995;373:523-527.
28. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99-102. (Pubitemid 26332733)
29. Moriguchi S, Shioda N, Yamamoto Y, Tagashira H, Fukunaga K. The T-type voltage-gated calcium channel as a molecular target of the novel cognitive enhancer ST101: enhancement of longterm potentiation and CaMKII autophosphorelation in rat cortical slices. J Neurochem. 2012;121:44-53.
30. Anderson D, Mehaffey WH, Iftinca M, Rehak R, Engbers JDT, Hameed S, et al. Regulation of neuronal activity by Cav3-Kv4 channel signaling complexes. Nat Neurosci. 2010;13:333-337.
31. Jang C, Choi JK, Na YJ, Jang B, Wasco W, Buxbaum JD, et al. Calsenilin regulates presenilin 1/γ-secretase-mediated N-cadherin ε-cleavage and β-catenin signaling. FASEB J. 2011;25: 4174-4183.
32. Kumar VB, Farr SA, Flood JF, Kamlesh V, Franko M, Banks WA, et al. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides. 2000; 21:1769-1775. (Pubitemid 32058851)
33. Morley JE, Farr SA, Flood JF. Antibody to amyloid β protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice. Neurobiol Learn Mem. 2002;78:125-138. (Pubitemid 34713254)
34. Banks WA, Farr SA, Morley JE, Wolf KM, Geylis V, Steinitz M. Anti-amyloid β protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment. Exp Neurol. 2007;206:248-256. (Pubitemid 47094769)